Phase I study of paclitaxel administered as a 1-hour infusion: Toxicity and pharmacokinetics

Seminars in Oncology

Volumn 24, Issue 6 SUPPL. 19, 1997, Pages

  Maier Lenz, H ^a   Hauns, B ^a   Haering, B ^a   Koetting, J ^a   Mross, K ^a   Unger, C ^a   Bauknecht, T ^a   Du Bois, A ^a   Meerpohl, H G ^a   Hollaender, N ^a   Diergarten, K ^a  

^a Department of Clinical Pharmacology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; BLADDER CANCER; BONE MARROW TOXICITY; BREAST CANCER; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISPOSITION; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PACLITAXEL;

EID: 0031473909     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)